Building on our solid operations in Europe, we are committed to creating a strong and sustainable clinical research infrastructure and bringing world-class health research skills and clinical trial execution to Africa
Our Brand Promise
We help advance health
through data excellence
- We specialise in public health, clinical and epidemiological research.
- We have a strong track record of collaborating with both private and public partners globally.
- We contribute to the collection, management and reporting of robust and reliable data that impact people’s lives around the world.
See below to learn more about our new identity.
Our identity
Our Solutions

Interventional Studies
Planning and execution of your early stage trials to ensure timely completion of your clinical development programmes.

Capacity Building

Observational Studies

Implementation Research
Recent Blog Posts
Pharmalys at the World Vaccine Congress Europe 2025: Marieme Ba calls for a “Come and Build” Approach to Strengthening LMICs Clinical Research Ecosystems
From 13 to 16 October 2025, Pharmalys Founder & CEO Marieme Ba attended the World Vaccine Congress Europe in Amsterdam, one of the most influential global gatherings for vaccine development, innovation, and cross-sector collaboration. This year’s edition brought...
Strengthening GCLP Compliance at MSF Epicentre Laboratory, Mbarara
Pharmalys is pleased to announce the successful completion of a GCLP audit at the MSF Epicentre Laboratory in Mbarara, Uganda, conducted on 13-14 November 2025. Epicentre is a Médecins Sans Frontières (MSF) satellite dedicated to epidemiology, medical research, and...
Advancing GCLP Excellence at the UCL Cancer Institute, London
We are pleased to announce the successful completion of a GCLP audit at the ECMC GCLP Facility, UCL Cancer Institute, University College London, carried out on 20-21 November 2025 as part of Pharmalys’ ongoing commitment to strengthening global Good Clinical...



